The Scope of Percutaneous Biliary Cholangioscopy: Beyond Choledocholithiasis
Journal of Digestive Diseases · 2025
DOI: 10.1111/1751-2980.70027 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Digestive Diseases, 2025. Verfasst von Jake DiFatta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Interventional Radiology, Department of Radiology, University of Alabama Birmingham, Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Endoscopy, Digestive System. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Objective
To discuss less well‐defined indications for percutaneous cholangioscopy (PC) that have been described in case reports and other studies. The role of PC is expanding in the treatment of biliary and pancreatic pathologies and presents unique advantages and drawbacks when compared to other endovascular diagnostic and therapeutic modalities. The utility of cholangioscopy in the treatment of choledocholithiasis has been well defined, and therefore here we focus on other indications.
Methods
A thematic review was conducted by searching PubMed for studies reporting indications for PC since January 1, 2000. Relevant data were extracted, synthesized, and analyzed to identify trends and gaps in the use of this procedure.
Results
Indications for PC include indeterminate biliary strictures, tumor evaluation and staging, primary sclerosing cholangitis (PSC), hemobilia, foreign object retrieval, and pancreatic pathologies, and so on. PC is generally used when other techniques such as endoscopic retrograde cholangiopancreatography (ERCP) or magnetic resonance cholangiopancreatography (MRCP) are insufficient or contraindicated. Reasons for this include technical complexity, anatomic abnormalities, and cost. PC has similar rates of complication as other biliary techniques such as ERCP, albeit marginally higher rates of cholangitis, which can be successfully mitigated with antibiotics.
Conclusion
PC enables direct visual inspection of the biliary tree with correlative cholangiography to better appreciate and manage biliary pathology not amenable to peroral cholangioscopy, ERCP, or MRCP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Interventional Radiology, Department of Radiology, University of Alabama Birmingham, Birmingham, Alabama, USA.
Zitieren
APA
DiFatta, J., Mahler, C., Knight, A., & Raja, J. (2025). The Scope of Percutaneous Biliary Cholangioscopy: Beyond Choledocholithiasis. Journal of Digestive Diseases. https://doi.org/10.1111/1751-2980.70027
Vancouver
DiFatta J, Mahler C, Knight A, Raja J. The Scope of Percutaneous Biliary Cholangioscopy: Beyond Choledocholithiasis. Journal of Digestive Diseases. 2025. doi:10.1111/1751-2980.70027
BibTeX
@article{DiFatta2025,
author = {DiFatta, Jake and Mahler, Chase and Knight, Alyssa and Raja, Junaid},
title = {The Scope of Percutaneous Biliary Cholangioscopy: Beyond Choledocholithiasis},
journal = {Journal of Digestive Diseases},
year = {2025},
doi = {10.1111/1751-2980.70027}
}
EUVIMED